www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf<\/a><\/p> <\/p>
<\/p>
<\/p>
The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-06-08", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "745"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-06-08T10:56:15.757Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-06-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hidradenitis Suppurativa"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to support patients with hidradenitis suppurativa.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "746"}
, {"_about" : "http://data.parliament.uk/resources/225202", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/225202/answer", "answerText" : {"_value" : "
We are committed to delivering the Joint Committee on Vaccination and Immunisation\u2019s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.<\/p>
<\/p>
<\/p>
<\/p>
In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.<\/p>
<\/p>
<\/p>
<\/p>
General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.<\/p>
<\/p>
<\/p>
<\/p>
This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-09", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "226311"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-09T16:06:24.23Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Shingles: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what plans he has to ensure the vaccination of eligible people who have not previously accessed the shingles vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "226309"}
, {"_about" : "http://data.parliament.uk/resources/225203", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/225203/answer", "answerText" : {"_value" : "
There will be a review of the Public Health Outcomes Framework later in 2015. Any proposal to include shingles vaccination as an indicator will be considered as part of the review process.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-09T16:04:54.387Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Shingles: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether the shingles vaccination will be included as an indicator in the Public Health Outcomes Framework along with other recommended vaccination programmes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "226310"}
, {"_about" : "http://data.parliament.uk/resources/225204", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/225204/answer", "answerText" : {"_value" : "
We are committed to delivering the Joint Committee on Vaccination and Immunisation\u2019s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.<\/p>
<\/p>
<\/p>
<\/p>
In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.<\/p>
<\/p>
<\/p>
<\/p>
General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.<\/p>
<\/p>
<\/p>
<\/p>
This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-09", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "226309"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-09T16:06:24.137Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Shingles: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when the Government plans to make the shingles vaccine available to everyone who requests it in the 70-79 age group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "226311"}
, {"_about" : "http://data.parliament.uk/resources/225205", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/225205/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that shingles vaccine should be offered to all those aged 70 \u2013 79 years. The vaccine is being routinely offered to all those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.<\/p>
<\/p>
<\/p>
<\/p>
In the first year of the programme, 2013/14, shingles vaccination was offered to patients aged 70 and 79 years old. For 2014/15, we are offering vaccination to patients aged 70, 78 and 79 years old and, for 2015/16, we will offer the vaccine to patients aged 70 and 78 years old.<\/p>
<\/p>
<\/p>
<\/p>
We are committed to delivering the JCVI\u2019s recommendation in full. Eligibility criteria for immunisation in each year of the programme are informed by the volumes of vaccine that have been contracted and scheduled for delivery in that particular year.<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-03-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-03-09T15:54:49.803Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-03-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Shingles: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the current shingles vaccination schedule is for 70 to 79 year olds; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "226312"}
, {"_about" : "http://data.parliament.uk/resources/172549", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/172549/answer", "answerText" : {"_value" : "
The Drug Tariff sets out what National Health Service dispensing contractors will be paid for the products supplied as part of providing pharmaceutical services and the fees for providing those services in primary care.<\/p>
<\/p>
<\/p>
<\/p>
The current arrangements for paying for unlicensed medicines were introduced in 2011. These arrangements, unlike the ones for Scotland, do not require pharmacy contractors to obtain a whole-of-market quote from manufacturers. However, the Drug Tariff sets the price that the NHS pays to dispensing contractors for dispensing many of the most popular specials. Setting a reimbursement price, applied to all contractors, stops disparity of payment for these products and encourages dispensing contractors to obtain best value for the NHS, while also ensuring patients receive the medicines they need, when they need them. Due to the number of unlicensed medicines that can potentially be prescribed, it is not possible to list a reimbursement price for all available specials.<\/p>
<\/p>
<\/p>
<\/p>
Where the reimbursement price of a product has not been set, dispensing contractors are paid according to how the product is sourced. Where a dispensing contractor buys the product from a specials manufacturer or an importing company, they must claim the invoice price of the pack size used to dispense the product minus any discounts or rebates received.<\/p>
<\/p>
<\/p>
<\/p>
NHS England is responsible for commissioning pharmaceutical services in primary care and it is for NHS England to consider whether dispensing contractors have acted appropriately, including excessive claims for payment made by contractors. In addition, the General Pharmaceutical Council is responsible for regulating the pharmacy professions should there be any concerns of professional misconduct.<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-01-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-01-12T15:05:25.95Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Dermatology"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to curb excessive disparities in the cost of dispensing (a) dermatology and (b) non-dermatology preferred unlicensed dermatological preparations; and what steps he is taking to ensure that all pharmacies in England obtain a whole-of-market quote from manufacturers of such preparations, as is the case in Scotland.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "220033"}
, {"_about" : "http://data.parliament.uk/resources/91465", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/91465/answer", "answerText" : {"_value" : "
The Department is carefully assessing the All-Party Parliamentary Group on Skin\u2019s recommendations and we will provide our response by the end of October.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-13T14:15:45.647296Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-09-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sunbeds"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of the All-Party Parliamentary Group on Skin report on sunbed regulation, published in May 2014; when he plans to announce his Department's response to that report; and whether his Department is preparing secondary legislation to implement the conditions of that report.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "209022"}
, {"_about" : "http://data.parliament.uk/resources/90723", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/90723/answer", "answerText" : {"_value" : "
<\/p>
The business case referred to in the answer given on 2 August 2014 is the General Dental Council\u2019s (GDC) consultation document setting out the GDC\u2019s rationale for the proposed fee rise. The consultation closed on 4 September 2014 and the document is available at:<\/p>
<\/p>
<\/p>
<\/p>
www.gdc-uk.org/GDCcalendar/Consultations/Pages/Consultation-on-the-Annual-Retention-Fee-(ARF)-Level-for-2015.aspx<\/p>
<\/p>
<\/p>
<\/p>
The GDC is an independent body and therefore neither the Department nor The Professional Standards Authority for Health and Social Care as a formal role in reviewing the GDC\u2019s case. However, in my role as Parliamentary Under Secretary for Health, on 3 September 2014 I met with the GDC where this issue was discussed.<\/p>
<\/p>
<\/strong><\/p> <\/p>
Each year the Care Quality Commission (CQC) consults on its proposed fee structure for the following year. The CQC intends to publish a consultation on its proposed fee structure for 2015-16 and draft impact assessment in the next month. The final impact assessment will be published in 2015. These documents will be available on the CQC\u2019s website. Following consultation, the CQC will present its proposals to my Rt. Hon. Friend the Secretary of State for Health.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/90723/answer/attachment/1", "fileName" : {"_value" : "PQ208258 - Hansard Extract.docx"}
, "title" : "Hansard Extract"}
, "dateOfAnswer" : {"_value" : "2014-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-09-09T14:48:44.0749716Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-09-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Dental Council"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 2 September 2014, Official Report, on the General Dental Council, if (a) his Department and (b) the Professional Standards Authority For Health and Social Care will publish its review of the business case for the increase in years charged by the General Dental Council; and if similar reviews will be published of the Care Quality Commission increase in fees to dental professionals.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "208258"}
, {"_about" : "http://data.parliament.uk/resources/79367", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/79367/answer", "answerText" : {"_value" : "
The General Dental Council is an independent body, directly accountable to Parliament. It is therefore for the General Dental Council to determine its top-level pay. However the Department expects all regulators to show restraint and to set salaries which are appropriate.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-09-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-09-01T13:57:02.0702492Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-07-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Dental Council"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what his policy is on top-level pay at the General Dental Council.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/103", "label" : {"_value" : "Biography information for Sir Paul Beresford"}
}
, "tablingMemberConstituency" : {"_value" : "Mole Valley"}
, "tablingMemberPrinted" : [{"_value" : "Sir Paul Beresford"}
], "uin" : "207017"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Sir+Paul+Beresford&_page=1&max-ddpCreated=2016-02-25T20%3A15%3A27.303Z&answeringDeptId=17", "page" : 0, "startIndex" : 1, "totalResults" : 13, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}